(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-1.35%) $82.72
(6.40%) $2.05
(0.02%) $2 347.60
(-0.29%) $27.46
(4.11%) $960.00
(-0.22%) $0.933
(-0.36%) $10.99
(-0.55%) $0.796
(1.66%) $93.40
-1.97% INR 1 007.70
Live Chart Being Loaded With Signals
NATCO Pharma Limited, a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients (APIs)...
Stats | |
---|---|
Dagens volum | 447 878 |
Gjennomsnittsvolum | 1.02M |
Markedsverdi | 180.49B |
EPS | INR0 ( 2024-02-13 ) |
Neste inntjeningsdato | ( INR0 ) 2024-05-27 |
Last Dividend | INR7.00 ( 2023-08-22 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 14.21 |
ATR14 | INR0.830 (0.08%) |
Volum Korrelasjon
NATCO Pharma Limited Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
NATCO Pharma Limited Korrelasjon - Valuta/Råvare
NATCO Pharma Limited Økonomi
Annual | 2022 |
Omsetning: | INR27.07B |
Bruttogevinst: | INR20.80B (76.83 %) |
EPS: | INR39.18 |
FY | 2022 |
Omsetning: | INR27.07B |
Bruttogevinst: | INR20.80B (76.83 %) |
EPS: | INR39.18 |
FY | 2022 |
Omsetning: | INR19.05B |
Bruttogevinst: | INR12.23B (64.22 %) |
EPS: | INR9.32 |
FY | 2021 |
Omsetning: | INR16.90B |
Bruttogevinst: | INR10.82B (64.04 %) |
EPS: | INR24.20 |
Financial Reports:
No articles found.
NATCO Pharma Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR3.50 (N/A) |
INR0.750 (N/A) |
INR1.250 (N/A) |
INR0 (N/A) |
INR7.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.200 | 1996-12-31 |
Last Dividend | INR7.00 | 2023-08-22 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 33 | -- |
Total Paid Out | INR56.90 | -- |
Avg. Dividend % Per Year | 0.68% | -- |
Score | 2.39 | -- |
Div. Sustainability Score | 1.998 | |
Div.Growth Potential Score | 3.28 | |
Div. Directional Score | 2.64 | -- |
Year | Amount | Yield |
---|---|---|
1996 | INR0 | 0.00% |
1997 | INR0 | 0.00% |
1998 | INR0 | 0.00% |
1999 | INR0 | 0.00% |
2000 | INR0 | 0.00% |
2001 | INR0 | 0.00% |
2002 | INR0 | 0.00% |
2003 | INR0 | 0.00% |
2004 | INR0 | 0.00% |
2005 | INR0 | 0.00% |
2006 | INR0 | 0.00% |
2007 | INR0 | 0.00% |
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR8.50 | 1.07% |
2019 | INR7.00 | 1.01% |
2020 | INR8.75 | 1.42% |
2021 | INR3.50 | 0.36% |
2022 | INR6.25 | 0.68% |
2023 | INR8.25 | 1.49% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SPIC.NS | Dividend Junior | 2023-09-20 | Annually | 3 | 0.70% | |
MPHASIS.NS | Dividend Knight | 2023-07-05 | Annually | 20 | 1.43% | |
HESTERBIO.NS | Dividend Junior | 2023-09-13 | Annually | 10 | 0.31% | |
BIRLACABLE.NS | Dividend Junior | 2023-09-04 | Sporadic | 11 | 0.93% | |
RAYMOND.NS | Dividend Junior | 2023-06-23 | Sporadic | 29 | 0.15% | |
KOTARISUG.NS | Dividend Junior | 2023-08-03 | Sporadic | 11 | 0.58% | |
EVERESTIND.NS | Dividend Junior | 2023-08-14 | Annually | 22 | 0.75% | |
AMBIKCO.NS | Dividend Junior | 2023-09-22 | Annually | 17 | 1.61% | |
SYRMA.NS | No Dividend Player | 2023-09-01 | Insufficient data to determine frequency | 2 | 0.18% | |
NEWGEN.NS | Dividend Junior | 2023-06-20 | Annually | 7 | 2.26% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.334 | 1.500 | 3.32 | 4.99 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.251 | 1.500 | 8.32 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 97.83 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 19.24 | 2.00 | 3.59 | 7.17 | [0 - 30] |
freeCashFlowPerShareTTM | 19.24 | 2.00 | 0.380 | 0.760 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.783 | 1.000 | 0.290 | 0.290 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.401 | 1.000 | 3.98 | 3.98 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 1.998 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 14.18 | 1.000 | 8.67 | 0 | [1 - 100] |
returnOnEquityTTM | 0.251 | 2.50 | 8.92 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 19.24 | 2.00 | 3.59 | 0.760 | [0 - 30] |
dividendYielPercentageTTM | 0.939 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 19.24 | 2.00 | 3.59 | 7.17 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -3.18 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0900 | 1.000 | -0.250 | 0 | [0.1 - 0.5] |
Total Score | 3.28 |
NATCO Pharma Limited
NATCO Pharma Limited, a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients (APIs). It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, ovary, etc.; and APIs in various categories, such as oncology, central nervous system, pain management, and CV care. The company also offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina and CHF. The company markets its products in approximately 40 countries, including India, the United States, and internationally. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.